Abstract
The increased rate of early detection of breast cancer due to widespread mammographic screening has led to an increased incidence not only of in situ but also microinvasive carcinoma (MC). MC has been reported to have a favourable prognosis, but specific definitions have varied in the past making the clinical significance of this entity a subject of debate. In fact, although the diagnosis of MC often appears in pathology reports, this term has not been used in a consistent, standardized manner. In addition, the histological diagnosis of MC can be problematical for the pathologist due to a variety of in situ patterns and artefacts that may be misinterpreted as stromal invasion. Definitions and diagnostic criteria of MC are reviewed and discussed. Based on a review of literature, incidence of axillary lymph node involvement, according to different definitions of microinvasion, is reported.
Similar content being viewed by others
Abbreviations
- DCIS:
-
ductal carcinoma in situ
- DCIS-MI:
-
ductal carcinoma in situ with microinvasion
- IHC:
-
immunohistochemistry
- LCIS:
-
lobular carcinoma in situ
- MC:
-
microinvasive carcinoma
- NCB:
-
needle core biopsy
- VANCB:
-
vacuum-assisted needle core biopsy
- SMM-HC:
-
smooth muscle myosin heavy chain
- SLN:
-
sentinel lymph node
References
Georgian-Smith D, Lawton TJ (2001) Calcifications of lobular carcinoma in situ of the breast: radiologic–pathologic correlation. AJR 176:1255–1258
Sapino A, Frigerio A, Peterse JL et al (2000) Mammographically detected in situ lobular carcinoma of the breast. Virchows Arch 436:421–430
Hanby AM, Hughes TA (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52:58–66
Tavassoli FA (1999) Pathology of the breast, 2nd edn. Appleton & Lange, Stanford
Boecker W, Parker S, Schulz-Wendtland R et al (2006) Ductal carcinoma in situ. In: Boecker W (ed) Preneoplasia of the breast. A new conceptual approach to proliferative breast disease. Elsevier GmbH, Munich
Nemoto T, Castillo N, Tsukada Y et al (1998) Lobular carcinoma in situ with microinvasion. J Surg Oncol 67:41–46
Hoda SA, Chiu A, Prasad ML et al (2000) Are microinvasion and micrometastasis in breast cancer mountains or molehills? Am J Surg 180:305–308
Lagios MD, Wesdahl PR, Margolin FR et al (1982) Duct carcinoma in situ. Relationship of extent of non invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309–1314
Schuh ME, Nemoto T, Penetrante RB et al (1986) Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 121:1303–1307
Patchefsky AS, Schwartz GF, Finkelstein SD et al (1989) Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731–741
Wong JH, Kopald KH, Morton DL (1990) The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298–1301
Silverstein MJ, Waisman JR, Gamagami P et al (1990) Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 66:102–108
National Coordinating Group for Breast Cancer Screening Pathology (1990) Pathology reporting in breast cancer screening. NHSBSP Publications, Sheffield
Sloane JP (1991) Pathology reporting in breast cancer screening. J Clin Pathol 44:710–725
Rosner D, Lane WW, Penetrante R (1991) Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 67:1498–1503
Solin LJ, Fowble BL, Yeh IT et al (1992) Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961–968
Silver SA, Tavassoli FA (1998) Mammary ductal carcinoma in-situ with microinvasion. Cancer 82:2382–2390
De Mascarel I, MacGrogan G, Mathoulin-Pelissier S et al (2002) Breast ductal carcinoma in situ with microinvasion. A definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 94:2134–2142
Sobin LH, Wittekind CH (eds) (1997) Breast tumors in TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York
National Coordinating Group for Breast Cancer Screening Pathology (1995) Pathology reporting in breast cancer screening, 2nd edn. NHSBSP Publications, Sheffield
Tavassoli FA, Devilee P (eds) (2003) World health organization classification of tumours. Pathology and genetics of the tumours of the breast and female genital organs. IARC, Lyon
Perry N, Broeders M, de Wolf C et al (eds) (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Communities, Luxemburg
Rosen PP (2001) Rosen’s breast pathology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
Damiani S, Ludvikova M, Tomasic G et al (1999) Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch 434:227–234
Schnitt SJ (1998) Microinvasive carcinoma of the breast: a diagnosis in search of a definition. Adv Anat Pathol 5:367–372
Yaziji H, Gown AM, Sneige N (2000) Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol 7:100–109
Werling W, Hwang H, Yaziji H et al (2003) Immunohistochemical distinction of invasive from non-invasive breast lesions. A comparison study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 27:82–90
Fischer ER (1997) Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin 47:52–64
Olivotto I, Levine M (2001) Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). JAMC 165:912–913
National Coordinating Group for Breast Cancer Screening Pathology (2005) Pathology reporting of breast disease. NHSBSP Publication No 58, Sheffield. www.rcpath.org
Kinne DW, Petrek JA, Osborne MP et al (1989) Breast carcinoma in situ. Arch Surg 124:33–36
Simpson T, Thirlby RC, Dail DH et al (1992) Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up. Arch Surg 127:468–472
Silverstein MJ (1997) Ductal carcinoma in situ with microinvasion. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast, 1st edn. Williams and Wilkins, Baltimore
Aktar S, Michaelson RA, Hutter RV et al (1998) Predictors of axillary lymph node metastases in small (one centimeter or less) T1a, b primary breast cancer. J Clin Oncol 17:120a
Jimenez RE, Visscher DW (1998) Clinicopathologic analysis of microscopically invasive breast carcinoma. Hum Pathol 29:1412–1419
Le Bouedec G, Penault Llorca F, de Latour M et al (1999) Carcinoma canalaire microinvasif du sein. J Gynecol Obstet Biol Reprod 28:10–16
Mann GB, Port ER, Rizza C et al (1999) Six-year follow-up of patients with microinvasion. Ann Surg Oncol 6:591–598
Zavotsky J, Hansen n, Brennan MB et al (1999) Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85:2439–2443
Klauber-DeMore N, Tan LK, Liberman L et al (2000) Sentinel lymph node biopsy: it is indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7:636–642
Padmore RF, Fowble B, Hoffman J et al (2000) Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Cancer 88:1403–1409
Prasad ML, Osborne MP, Giri DD et al (2000) Microinvasive carcinoma (T1 mic) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol 24:422–428
Cox CE, Nguyen K, Gray RJ et al (2001) Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67:513–521
Wasserberg N, Morgenstern S, Schachter J et al (2002) Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Ann Surg 137:1249–1252
Wong SL, Chao C, Edwards MJ et al (2002) Frequency of sentinel node metastases in patients with favourable breast cancer histologic subtypes. Am J Surg 184:492–498
Intra M, Zurrida S, Maffini F et al (2003) Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg 10:1160–1165
Yang M, Moriya T, Oguma M et al (2003) Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int 53:422–428
Buttarelli M, Houvenaeghel G, Martino M et al (2004) Prelevement de ganglions sentinelles dans les carcinomes intracanalaires du sein (± microinvasion). Ann Chir 129:1105–1111
Giard S, Chauvet MP, Houpeau JL et al (2005) Le ganglion sentinelle sans curage systematique dans le cancer du sein: bilan d’une experience de 1000 interventions. Gynelcol Obstet Fertil 33:213–219
Wilkie C, White L, Dupont D et al (2005) An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190:563–566
Katz A, Gage I, Evans S et al (2006) Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 191:761–766
Leidenius M, Salmenkivi K, Von Smitten K et al (2006) Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 94:380–384
Gray RJ, Mulheron B, Pockaj BA et al (2007) The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era. Am J Surg 194:845–849
Le Bouedec G, de Lapasse C, Mishellany F et al (2007) Microinvasive ductal carcinoma of the breast. Role of sentinel lymph node biopsy. Gynecol Obstet Fertil 35:317–322
Zavagno G, Belardinelli V, Marconato R et al (2007) Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast 16:146–151
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bianchi, S., Vezzosi, V. Microinvasive Carcinoma of the Breast. Pathol. Oncol. Res. 14, 105–111 (2008). https://doi.org/10.1007/s12253-008-9054-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-008-9054-8